Related Articles
Schedule-dependent antitumor activity of the combination with erlotinib and docetaxel in human non-small cell lung cancer cells with EGFR mutation, KRAS mutation or both wild-type EGFR and KRAS
Pre-radiation enhances the cytotoxicity of docetaxel in head and neck squamous cell carcinoma cells
Effects of D-allose in combination with docetaxel in human head and neck cancer cells
Efficacy of gefitinib‑celecoxib combination therapy in docetaxel‑resistant prostate cancer
Cell cycle effects of fatty acid derivatives of cytarabine, CP-4055, and of gemcitabine, CP-4126, as basis for the interaction with oxaliplatin and docetaxel